🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

9 recruiting trials

for Obstructive Hypertrophic Cardiomyopathy (oHCM)

BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy NCT07755904Phase 33 sites📍 Manhasset📍 Rock Hill📍 Plano Braveheart Bio, Inc. · Tests: BHB-1893, Metoprolol A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM) NCT05489705n/a101 sites📍 Anchorage📍 Tucson📍 Little Rock Bristol-Myers Squibb · Tests: Mavacamten, Non-mavacamten symptomatic oHCM therapy Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM NCT05836259Phase 1, Phase 210 sites📍 La Jolla📍 San Francisco📍 Atlanta Tenaya Therapeutics · Tests: TN-201 Mavacamten Outcomes in Hypertrophic Cardiomyopathy (HCM) and the Associated Patient and Physician Experiences in the US NCT07557498n/a1 site📍 Bollington Bristol-Myers Squibb · Tests: Mavacamten A Study to Assess the Safety of Mavacamten in Korean Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy NCT06146660n/a2 sites📍 Seoul📍 Seoul Bristol-Myers Squibb · Tests: Mavacamten Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM NCT06023186n/a1 site📍 Charlottesville Michael Ayers · Tests: mavacamten A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China NCT07361289n/a15 sites📍 Beijing📍 Beijing📍 Beijing Bristol-Myers Squibb · Tests: Mavacamten Mavacamten Post-marketing Surveillance in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan NCT07383025n/a1 site📍 Tokyo Bristol-Myers Squibb · Tests: Mavacamten Ademetionine in Obstructive Hypertrophic Cardiomyopathy NCT07367724Phase 23 sites📍 Beijing📍 Shanghai📍 Xinjiang China National Center for Cardiovascular Diseases · Tests: Ademetionine 1,4-Butanedisulfonate, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy